[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial].
Marc G. Besselink(Amsterdam Neuroscience), Hein G. Gooszen(Cal Humanities), Hjalmar C. van Santvoort(University Medical Center Utrecht), Harro M. Timmerman, E. van der Harst, Camiel Rosman(Radboud University Nijmegen), Marja A. Boermeester(Amsterdam University Medical Centers), Ben Witteman(Ziekenhuis Gelderse Vallei), Harry van Goor(Radboud University Nijmegen), Peter J. Wahab, Bert van Ramshorst(St. Antonius Ziekenhuis), Thomas L. Bollen, Menno A. Brink, C. Dejong, Erik Buskens(Radboud University Nijmegen), M. A. Cuesta, L. M. A. Akkermans, R J Ploeg, C.J.H.M. van Laarhoven(Radboud University Nijmegen), Alexander F. Schaapherder, Vincent B. Nieuwenhuijs(Isala), Casper H.J. van Eijck(Erasmus MC)
PubMed
March 22, 2008
Cited by 39
Related Papers
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914